Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amy McDonough"'
Autor:
Amy McDonough, Daniela C. Rodríguez
Publikováno v:
Globalization and Health, Vol 16, Iss 1, Pp 1-18 (2020)
Abstract Background Global health donors are increasingly transitioning funding responsibility to host governments as aid budgets plateau or decline and countries meet development and disease burden goals. Civil society organizations (CSOs) can play
Externí odkaz:
https://doaj.org/article/1378feed66c4406098abc1f022bbf74b
Autor:
Chris De Savi, Glen Andrews, Anthony Ronald Cook, Rhona J. Cox, Peter Stewart Gilmour, Simon Young, Daniel J. Warner, Beth Parker, Dickinson Mark, Amy McDonough, Matthew Dearman, Louis C. Morrill, Rob Riley
Publikováno v:
Journal of Medicinal Chemistry. 57:4661-4676
Oral phosphodiesterase 4 (PDE4) inhibitors, such as cilomilast and roflumilast, have been shown to be efficacious against chronic obstructive pulmonary disease (COPD). However, these drugs have been hampered by mechanism-related side effects such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d2b641774a05b708c970ec898a1ac4
https://doi.org/10.1021/jm5001216
https://doi.org/10.1021/jm5001216
Autor:
Anjali Kumar, Amy McDonough, Roger B. Clark, Lyn Libertine, Greg LaRosa, Roger Rush, Daniel Elbaum, Diana Lamppu
Publikováno v:
Journal of Medicinal Chemistry. 57:3966-3983
Herein we report the design, synthesis, and structure-activity relationships for a new class of α7 nicotinic acetylcholine receptor (nAChR) modulators based on the 2-((pyridin-3-yloxy)methyl)piperazine scaffold. The oxazolo[4,5-b]pyridine, (R)-18, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb08d7ccdd44e28b2851dbdbc7fd093
https://doi.org/10.1021/jm5004599
https://doi.org/10.1021/jm5004599
Autor:
Stefan Sackmann, Amy McDonough
Publikováno v:
CEC
This study examines the impact of reported lapses in corporate governance, using event study analysis to explore the announcement effect of public reprimand letters issued for violations of corporate governance regulations. No evidence is found that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c15abb49eb9fcd002c68a9152c240826
https://doi.org/10.1109/cec.2009.60
https://doi.org/10.1109/cec.2009.60